整合网络分析识别新诊断多发性骨髓瘤发病与进展的新型驱动因素
研究对MMRF CoMMpass研究中450例新诊断多发性骨髓瘤患者的分子与临床数据行整合网络生物学分析,构建MMNet网络模型,揭示疾病分期、克隆性与早期进展相关的分子模式,验证CDC42BPA和CLEC11A为MMSET相关骨髓瘤的新调控因子与候选治疗靶点,并发现新的四基因预后特征及与高危骨髓瘤相关的新基因。
要点
- 构建MMNet网络模型,揭示临床特征与基因组标志物间的新关联。
- 验证CDC42BPA和CLEC11A为MMSET相关骨髓瘤的新调控因子和候选治疗靶点。
- 发现新的四基因预后特征及与高危骨髓瘤相关的新基因。
核心结论
- 对CoMMpass数据的整合网络分析为多发性骨髓瘤疾病生物学提供了新见解,并为诊断、分层提供了改进的分子特征及额外治疗靶点。
研究设计与样本
- 研究采用整合网络生物学方法,分析来自MMRF CoMMpass研究中450例新诊断多发性骨髓瘤患者的分子与临床数据。
主要发现
- 构建了新的骨髓瘤网络模型(MMNet),揭示复杂的分子疾病模式及临床特征与基因组标志物间的新关联。
- 基因组改变和共表达基因群与疾病分期、肿瘤克隆性和早期进展相关。
- 验证CDC42BPA和CLEC11A为MMSET相关骨髓瘤的新调控因子和候选治疗靶点。
- 利用MMNet发现与高危骨髓瘤相关的新基因,并识别出一个新的四基因预后特征。
- 识别出由网络特征定义的新患者类别,这些类别富集了临床相关遗传事件、通路和失调基因。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple myeloma (MM) is an incurable malignancy of bone marrow plasma cells characterized by wide clinical and molecular heterogeneity. In this study we applied an integrative network biology approach to molecular and clinical data measured from 450 patients with newly diagnosed MM from the MMRF (Multiple Myeloma Research Foundation) CoMMpass study. A novel network model of myeloma (MMNet) was constructed, revealing complex molecular disease patterns and novel associations between clinical traits and genomic markers. Genomic alterations and groups of coexpressed genes correlate with disease stage, tumor clonality and early progression. We validated CDC42BPA and CLEC11A as novel regulators and candidate therapeutic targets of MMSET-related myeloma. We then used MMNet to discover novel genes associated with high-risk myeloma and identified a novel four-gene prognostic signature. We identified new patient classes defined by network features and enriched for clinically relevant genetic events, pathways and deregulated genes. Finally, we demonstrated the ability of deep sequencing techniques to detect relevant structural rearrangements, providing evidence that encourages wider use of such technologies in clinical practice. An integrative network analysis of CoMMpass data identified new insights into multiple myeloma disease biology and provided improved molecular features for diagnosing and stratifying patients, as well as additional molecular targets for therapeutic alternatives.
引用
- Laganà A, Perumal D, Melnekoff D, et al. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma. Leukemia. 2017. PMID: 28642592. doi:10.1038/leu.2017.197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。